Agentura Science Pro Spol. s.r.o.

Olomouc 772 00

0 studies enrolling now · 1 studies all time

What they study most

Dyslipidemia, Type2 Diabetes

Studies at this site

• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early